[단독] 한미약품 오너2세 임종훈…PEF ‘파마앤파트너스’ 설립

This article reveals how a second-generation chaebol heir is building independent investment platforms separate from traditional family business structures. By establishing Pharma&Partners, a biotech-focused PEF with loyalists from past internal disputes, he is diversifying beyond minority shareholding into active venture investing. This reflects a broader trend in Korean conglomerates where governance conflicts catalyze entrepreneurial spin-offs and create new investment ecosystems outside the main business group.